News Summary: Targeted cancer drug approved

Published



SMART BOMB DRUG: Federal health regulators approved an innovative breast cancer drug on Friday that targets tumor cells while sparing healthy ones.

PHARMA COCKTAIL: The drug Kadcyla from Roche combines the older drug Herceptin with a powerful chemotherapy drug and a third chemical linking the medicines together.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.